glp 1 off shortage list GLP-1 No Longer on FDA's Drug Shortages improve for Lilly's GLP-1
Description
I was exercising
Interestingly, tirzepatide, a dual-acting GIP/GLP-1 receptor agonist that is now clinically approved for both obesity and T2D, was designed with an amino acid sequence closely resembling that of native GIP, resulting in strong preference for GIPR binding over the GLP-1R
GLP-1 also suppresses glucagon release, thus helping maintain blood glucose levels
JAMA Intern Med 2022
But losing more than 1.5%2% of body weight per week raises the risk of muscle and bone loss
Wu GJ, et al
